MEND-CABG (MC-1 to Eliminate Necrosis and Damage in Coronary Artery Bypass Graft Surgery)
Status:
Completed
Trial end date:
2005-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether MC-1 is effective and safe in reducing
cardiovascular and neurological events in patients undergoing high-risk coronary artery
bypass surgery